Alliance Growers Corp’s Complete Fundamental Research Corp

Alliance Growers Corp. (CSE: ACG) –
Site Work Commences on the Cannabis Biotech Complex /BioCanna Tech Acquisition Completed
Sector/Industry: Cannabis


To View Complete Analysis:
Full Research Click Here


Market Data (as of December 13, 2018)

Current Price C$0.10
Fair Value C$0.35
Rating* BUY
Risk* 5
52 Week Range C$0.20 – C$1.39
Shares O/S 82,526,361
Market Cap C$8.25 mm
Current Yield N/A
P/B 2.88x
YoY CSE -40.52%

*see back of report for rating and risk definitions.
* All figures in C$ unless otherwise specified.


 Alliance Growers Corp. (“company”, “Alliance”) announced new
production capacity estimates for their cannabis biotech complex
located in Mission, British Columbia. Estimated cannabis plantlet
production is now 10 million per annum versus the previous
estimate of 7 million plantlets.

 The company has expanded their agreement with WFS
Pharmagreen (“Pharmagreen”) to include a commercial CBD
commercial hemp operation, beginning with disease free
genetically female only plantlets at the cannabis biotech complex.
The company anticipates 2019 pilot production of 24,000 lbs of
high-quality CBD biomass.

 Alliance closed their acquisition of BioCanna Tech, a late-stage
Cannabis Act License applicant located in Quebec. Once
expanded to full capacity, the BioCanna Tech facility is expected

to produce 2,500 kg of dried cannabis equivalent.

 Alliance also increased their equity stake in Canwe Growers Inc.
(“Canwe Growers”) – a late-stage ACMPR applicant based in
Ontario. Canwe Growers has a post-money valuation of $25
 We are revising our fair value estimate of $0.88 per share to
$0.35 per share.

To View Complete Analysis:
Full Research Click Here

Please read important disclosures in the report

Leave a Reply

Notify of